The Biden administration has directed HHS to invest over $12 billion in COVID-19 serial testing, $10 billion of which is allocated for asymptomatic screening testing in K-12 schools and $2.25 billion is set aside for testing underserved populations. The administration hopes to ramp up COVID-19 screening testing in the hopes that schools can reopen for in-person classes for the last few months of the school year. State health departments can expect to receive the final financial awards by the beginning...